Not applicableStudy completedNCT06903754What this trial is testingISGLT2 in Patients Without DM With Acute MIWho this might be right forAcute Coronary SyndromesHeart Failure Mohammed VI University Hospital 450
Large-scale testing (Phase 3)Study completedNCT04304261What this trial is testingEffects of SGLT2i on the Cognitive Function in T2DM Patient (ESCDP)Who this might be right forDiabetes Mellitus, Type 2Cognitive Functions Confusion Third Military Medical University 100
Not applicableNot Yet RecruitingNCT06739486What this trial is testingEfficacy of Sodium Glucose Cotransporter 2 Inhibitors on Non-Alcoholic Fatty Liver DiseaseWho this might be right forNon Alcholic Fatty Liver DiseaseHepatic SteatosisHepatic Fibrosis+1 more Assiut University 100
Testing effectiveness (Phase 2)Study completedNCT04818034What this trial is testingThe Effect of Sodium-glucose Cotransporter (SGLT) 2 Inhibitors on Cystine Stone Formation: A Preliminary StudyWho this might be right forCystinuria University of California, San Francisco 10
Post-approval studies (Phase 4)Not Yet RecruitingNCT07547878What this trial is testingRapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)Who this might be right forChronic Kidney DiseaseType 2 Diabetes Baylor Research Institute 64
Testing effectiveness (Phase 2)UnknownNCT04419337What this trial is testingPioglitazone and SGLT2 Inhibitors vs. DPP4 Inhibitors in Patients With StrokeWho this might be right forDiabetes MellitusStroke Chang Gung Memorial Hospital 200
Not applicableStudy completedNCT07269197What this trial is testingAssociation of SGLT2 Inhibitors Therapy With Elastographic and Molecular Markers of Liver Injury in Type 2 DiabetesWho this might be right forNon-Alcoholic Fatty Liver DiseaseDiabetes Mellitus, Type 2 Josip Juraj Strossmayer University of Osijek 67
Not applicableStudy completedNCT05990296What this trial is testingEvaluating Strategies to Improve Guideline Directed Medical Therapy: The GDMT Research, Education & Assist Trial for Heart Failure CareWho this might be right forHeart FailureHeart Failure With Reduced Ejection Fraction Geisinger Clinic 4,306
Post-approval studies (Phase 4)Study completedNCT04461041What this trial is testingEmpagliflozin and Cardiac Remodelling in People Without DiabetesWho this might be right forCardiovascular DiseasesLeft Ventricular Hypertrophy Unity Health Toronto 169
Post-approval studies (Phase 4)Study completedNCT06825156What this trial is testingMetabolic and Renal Outcomes in Cardiac Surgery Patients Receiving SGLT2 InhibitorsWho this might be right forAcute Kidney Injury Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 60
Post-approval studies (Phase 4)Study completedNCT01939496What this trial is testingEvaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive AgentsWho this might be right forDiabetes Mellitus, Type 2Hypertension Janssen Scientific Affairs, LLC 171
Not applicableActive Not RecruitingNCT07198191What this trial is testingSGLT2 Inhibitor Use After Acute Myocardial Infarction in Patients With Type 2 Diabetes: A Nationwide Cohort StudyWho this might be right forAcute Myocardial Infarction (AMI)Type 2 Diabetes Mellitus (T2DM) Yonsei University 200,000
Very early researchLooking for participantsNCT06430684What this trial is testingFeasibility Trial of Sodium-GLucose coTransporter 2 INhibitors in Pediatric Chronic KIDney DiSeaseWho this might be right forChronic Kidney DiseasesPediatric Kidney Disease Ann & Robert H Lurie Children's Hospital of Chicago 40
Post-approval studies (Phase 4)Looking for participantsNCT06625073What this trial is testingRandomized Trial of SGLT2i in Heart Transplant RecipientsWho this might be right forHeart TransplantCardiovascular DiseaseKidney Disease VA Office of Research and Development 200
Post-approval studies (Phase 4)UnknownNCT06350487What this trial is testingThe Efficacy of Enavogliflozin in Heart Failure With Preserved Ejection FractionWho this might be right forHeart Failure, Preserved Ejection Fraction Samsung Medical Center 154
Not applicableUnknownNCT05934071What this trial is testingEffects of the Sodium-glucose Cotransporter 2 Inhibitors+Sacubitril/Valsartan Therapy in Patients With HFrEF.Who this might be right forHeart FailureVentricular RemodelingVentricular Dysfunction Fondazione Policlinico Universitario Agostino Gemelli IRCCS 160
Not applicableStudy completedNCT02500186What this trial is testingThe Clinical Study to Assess the Effect of the Amount of Carbohydrate Intake and Meals Differing in Glycemic Index (GI) in Patients Treated With a Sodium-dependent Glucose Cotransporter 2 (SGLT2) InhibitorWho this might be right forDiabetes Melltius, Type 2 Kansai Electric Power Hospital 24
Not applicableUnknownNCT06137430What this trial is testingEffect of Sodium Glucose Cotransporter 2 Inhibitiors on Left Ventricular Remodeling Among Diabetic and Non Diabetic Patients With Chronic Heart FailureWho this might be right forSGLT2 Inhibitiors Remodeling EffectChronic Heart Disease Assiut University 98
Large-scale testing (Phase 3)Study completedNCT03968224What this trial is testingEffectiveness of Dapagliflozin for Weight LossWho this might be right forPreDiabetesObesity, MorbidDiabetes Mellitus, Type 2 Centro Medico Nacional Siglo XXI IMSS 160
Not applicableLooking for participantsNCT06473844What this trial is testingEfficacy of SGLT2 Inhibitors in Adults With SepsisWho this might be right forSepsisInflammationSGLT2 Inhibitors+2 more Hospital Authority, Hong Kong 60